Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616756095> ?p ?o ?g. }
- W2616756095 endingPage "58" @default.
- W2616756095 startingPage "36" @default.
- W2616756095 abstract "Over the last few decades, there has been significant progress in the understanding of the pathogenetic mechanisms of the Acute Myeloid Leukemia (AML). However, despite important advances in elucidating molecular mechanisms, the treatment of AML has not improved significantly, remaining anchored at the standard chemotherapy regimen “3 + 7”, with the prognosis of patients remaining severe, especially for the elderly and for those not eligible for transplant procedures. The biological and clinical heterogeneity of AML represents the major obstacle that hinders the improvement of prognosis and the identification of new effective therapeutic approaches. To date, abundant information has been collected on the genetic and molecular alterations of AML carrying prognostic significance. However, not enough is known on how AML progenitors regulate proliferation and survival by redundant and cross-talking signal transduction pathways (STP). Furthermore, it remains unclear how such complicated network affects prognosis and therapeutic treatment options, although many of these molecular determinants are potentially attractive for their druggable characteristics. In this review, some of the key STP frequently deregulated in AML, such as PI3k/Akt/mTOR pathway, GSK3 and components of Bcl-2 family of proteins, are summarized, highlighting in addition their interplay. Based on this information, we reviewed new targeted therapeutic approaches, focusing on the aberrant networks that sustain the AML blast proliferation, survival and drug resistance, aiming to improve disease treatment. Finally, we reported the approaches aimed at disrupting key signaling cross-talk overcoming resistances based on the combination of different targeting therapeutic strategies." @default.
- W2616756095 created "2017-05-26" @default.
- W2616756095 creator A5000262370 @default.
- W2616756095 creator A5000637717 @default.
- W2616756095 creator A5021039346 @default.
- W2616756095 creator A5054794378 @default.
- W2616756095 creator A5067656597 @default.
- W2616756095 date "2017-08-01" @default.
- W2616756095 modified "2023-10-16" @default.
- W2616756095 title "Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia" @default.
- W2616756095 cites W122353466 @default.
- W2616756095 cites W1255676896 @default.
- W2616756095 cites W146999070 @default.
- W2616756095 cites W1487506158 @default.
- W2616756095 cites W1495123612 @default.
- W2616756095 cites W1509864609 @default.
- W2616756095 cites W1529003705 @default.
- W2616756095 cites W1532302462 @default.
- W2616756095 cites W1535776410 @default.
- W2616756095 cites W1585517331 @default.
- W2616756095 cites W1596038553 @default.
- W2616756095 cites W1607777232 @default.
- W2616756095 cites W1716978847 @default.
- W2616756095 cites W1908445283 @default.
- W2616756095 cites W1957739887 @default.
- W2616756095 cites W1964632863 @default.
- W2616756095 cites W1965616500 @default.
- W2616756095 cites W1968610346 @default.
- W2616756095 cites W1968904120 @default.
- W2616756095 cites W1969150166 @default.
- W2616756095 cites W1969660254 @default.
- W2616756095 cites W1970637701 @default.
- W2616756095 cites W1971028883 @default.
- W2616756095 cites W1971234510 @default.
- W2616756095 cites W1974300980 @default.
- W2616756095 cites W1974888028 @default.
- W2616756095 cites W1975191034 @default.
- W2616756095 cites W1976491501 @default.
- W2616756095 cites W1976883744 @default.
- W2616756095 cites W1977258127 @default.
- W2616756095 cites W1977978614 @default.
- W2616756095 cites W1978714931 @default.
- W2616756095 cites W1979602806 @default.
- W2616756095 cites W1979700215 @default.
- W2616756095 cites W1979915243 @default.
- W2616756095 cites W1981231641 @default.
- W2616756095 cites W1982219839 @default.
- W2616756095 cites W1982958012 @default.
- W2616756095 cites W1984621921 @default.
- W2616756095 cites W1984741878 @default.
- W2616756095 cites W1985271970 @default.
- W2616756095 cites W1985563073 @default.
- W2616756095 cites W1986568749 @default.
- W2616756095 cites W1986688227 @default.
- W2616756095 cites W1986785675 @default.
- W2616756095 cites W1988602328 @default.
- W2616756095 cites W1988824838 @default.
- W2616756095 cites W1989929255 @default.
- W2616756095 cites W1991463695 @default.
- W2616756095 cites W1992295816 @default.
- W2616756095 cites W1992672293 @default.
- W2616756095 cites W1992861698 @default.
- W2616756095 cites W1996103471 @default.
- W2616756095 cites W1996122750 @default.
- W2616756095 cites W1996383959 @default.
- W2616756095 cites W1996947212 @default.
- W2616756095 cites W1997608577 @default.
- W2616756095 cites W1997673739 @default.
- W2616756095 cites W1998038367 @default.
- W2616756095 cites W1998826441 @default.
- W2616756095 cites W2001025314 @default.
- W2616756095 cites W2001404126 @default.
- W2616756095 cites W2002393876 @default.
- W2616756095 cites W2002636911 @default.
- W2616756095 cites W2003380824 @default.
- W2616756095 cites W2003799931 @default.
- W2616756095 cites W2005880838 @default.
- W2616756095 cites W2006160114 @default.
- W2616756095 cites W2006964316 @default.
- W2616756095 cites W2007114641 @default.
- W2616756095 cites W2007190305 @default.
- W2616756095 cites W2007241783 @default.
- W2616756095 cites W2007757672 @default.
- W2616756095 cites W2008757142 @default.
- W2616756095 cites W2009183764 @default.
- W2616756095 cites W2009886463 @default.
- W2616756095 cites W2009966467 @default.
- W2616756095 cites W2011282245 @default.
- W2616756095 cites W2011477466 @default.
- W2616756095 cites W2012142261 @default.
- W2616756095 cites W2013765904 @default.
- W2616756095 cites W2015362281 @default.
- W2616756095 cites W2015507268 @default.
- W2616756095 cites W2016709307 @default.
- W2616756095 cites W2016969330 @default.
- W2616756095 cites W2017333581 @default.
- W2616756095 cites W2019555382 @default.
- W2616756095 cites W2020670611 @default.